Dargie H J
Br J Clin Pharmacol. 1986;21 Suppl 2(Suppl 2):155S-160S. doi: 10.1111/j.1365-2125.1986.tb02865.x.
Verapamil and nifedipine enhance the hypotensive and anti-anginal effects of beta-adrenoceptor blocking drugs. The combination of beta-adrenoceptor blocking drugs with nifedipine may pose fewer safety problems than the combination with verapamil especially in ischaemic heart disease when left ventricular function is suspect. Verapamil as a single agent may be as effective as a beta-adrenoceptor blocking drug in angina and provide a suitable alternative. Careful supervision is required when verapamil is combined with beta-adrenoceptor blockers for both angina and hypertension but reported clinical problems in hypertension are few.
维拉帕米和硝苯地平可增强β-肾上腺素受体阻断药的降压及抗心绞痛作用。β-肾上腺素受体阻断药与硝苯地平联用可能比与维拉帕米联用带来的安全性问题更少,尤其在怀疑左心室功能的缺血性心脏病中。维拉帕米作为单一药物在心绞痛治疗中可能与β-肾上腺素受体阻断药同样有效,并提供了合适的替代选择。维拉帕米与β-肾上腺素受体阻断药联用于治疗心绞痛和高血压时需要仔细监测,但报道的高血压临床问题较少。